semaglutide bend oregon Medical Weight Loss in Bend, OR | & Tirzepatide Ozempic Weight Loss Injections &
Description
Opportunities to optimize lifestyle interventions in combination with glucagon-like peptide1based therapy
The SUSTAIN 6 trial showed that subcutaneous semaglutide reduced major adverse cardiovascular events by 26% in patients with type 2 diabetes and established cardiovascular disease (hazard ratio 0.74, 95% CI 0.58-0.95)
If more than 5 days have passed since the missed dose, skip it and take your next dose on the usual scheduled day
However, the SURPASS and SURMOUNT trials did not report a significant VTE signal
How Do I Keep My GLP-1 Medications Cold
Documentation of your medication and dosing helps inform this evaluation
